At Boston Medical Center (BMC), caring for patients is a collaborative, multidisciplinary process. BMC’s Cancer Care Center organizes its services around each patient, bringing together the expertise of diverse specialists to manage care from the first consultation through treatment and follow-up visits. The Cancer Care Center is dedicated to providing treatment that is effective and innovative in curing and controlling cancer, while managing its impact on quality-of-life.
As the primary teaching affiliate of the Boston University Chobanian & Avedisian School of Medicine, BMC combines personal, patient-focused care with the state-of-the-art-expertise and technological advances of a major teaching hospital. BMC is at the forefront of clinical practice, surgical expertise, and research in oncology.
Patients with kidney cancer, also called renal cell carcinoma (RCC), work with a urologist who takes the lead in the diagnosis, monitoring, and treatment planning of individual patients. Surgery is usually the first treatment for patients with malignant kidney tumors.
The surgeons at BMC offer state-of-the-art surgical treatment and have extensive experience with using laparoscopic and robotic techniques to operate on kidneys. In fact, they performed some of the earliest such cases in the Boston area. When possible, the surgeons perform a partial nephrectomy, which involves removing only part of the kidney rather than a total radical nephrectomy, in which the entire kidney is removed.
The BMC team follows the National Cancer Institute and the American Urological Association guidelines for the treatment of renal cell carcinoma.
Conditions We Treat
Treatments and Services
- Kidney Cancer Treatments by Stage
- Radiofrequency Ablation for Cancer
- Cryotherapy
- Immunotherapy
- Chemotherapy
- Radiation Therapy
- Robotic Resection
Diagnostics and Treatments
Patient Resources
- American Cancer Society
- Kidney Cancer Association
- National Cancer Institute
- National Kidney Foundation
- Urology Care Foundation
Research Overview
Kidney Cancer Clinical Trials
Boston Medical Center has a wide variety of clinical trials mainly funded by the National Cancer Institute (NCI). NCI is coming up with new and innovative clinical trials for kidney cancers that are, or will be, available at Boston Medical Center.
CIRB #H-35254/SWOG #S1500 (PAPMET): A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib, Crizotinib, Savolitinib, and Sunitinib) in Metastatic Papillary Renal Carcinoma
HIRB #2016-19/Janssen RIVA STM4001: Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism